AI assistant
HAEMONETICS CORP — Director's Dealing 2011
Oct 26, 2011
31565_dirs_2011-10-26_75501cf2-9654-4c57-b0ff-9d4d6fb20bc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2011-10-25
Reporting Person: LINDOP CHRISTOPHER J (CFO & Vice President of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-23 | Common Stock | D | 195.0 | $60.41 | Disposed | 11175.0 | Direct |
| 2011-10-24 | Common Stock | D | 107.0 | $61.031 | Disposed | 11068.0 | Direct |
| 2011-10-24 | Common Stock | D | 107.0 | $61.031 | Disposed | 10961.0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $48.09 | 2014-01-25 | Common Stock (40545.0) | 40545.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $51.07 | 2014-10-24 | Common Stock (21238.0) | 21238.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.63 | 2015-10-23 | Common Stock (49020.0) | 49020.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.94 | 2016-10-27 | Common Stock (22036.0) | 22036.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.55 | 2015-10-22 | Common Stock (21441.0) | 21441.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.99 | 2017-10-27 | Common Stock (25095.0) | 25095.0 | Direct |
Footnotes
F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
F4: Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.